Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-21-003774
Filing Date
2021-02-16
Accepted
2021-02-16 06:14:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 125171
  Complete submission text file 0001493152-21-003774.txt   126845
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 21631930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002
Business Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002 650-529-8000
ACUTA CAPITAL PARTNERS, LLC (Filed by) CIK: 0001582844 (see all company filings)

EIN.: 452817402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G